Fennec Pharmaceuticals FENC
NASDAQ FENC
$12.39 -0.16 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fennec Pharmaceuticals (FENC) Price to Earnings (2010 - 2026)

Analysis

Fennec Pharmaceuticals (FENC) Price to Earnings (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Fennec Pharmaceuticals 432.85 Mn 391.60 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 190.88
Dec 31, 2025 -99.87
Sep 30, 2025 -421.61
Jun 30, 2025 -73.03
Mar 31, 2025 -144.37
Dec 31, 2024 -115.90
Sep 30, 2024 -24.01
Jun 30, 2024 -30.29
Mar 31, 2024 23.35
Dec 31, 2023 -115.83
Sep 30, 2023 -112.95
Jun 30, 2023 -43.54
Mar 31, 2023 -36.88
Dec 31, 2022 -37.62
Sep 30, 2022 -26.59
Jun 30, 2022 -28.76
Mar 31, 2022 -40.56
Dec 31, 2021 -26.89
Sep 30, 2021 -58.12
Jun 30, 2021 -48.40